Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$49.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Cambrex reaffirms FY 2014 outlook


Friday, 2 May 2014 07:00am EDT 

Cambrex Corp:Continues to expect FY 2014 sales, excluding the impact of foreign currency, will increase between 8 and 12 pct over FY 2013.FY 2014 EBITDA will be between $70 and $76 million.Reported revenue of $318 mln in FY 2013.FY 2014 revenue of $353 mln and EBITDA of $76 - Thomson Reuters I/B/E/S. 

Company Quote

34.82
0.57 +1.66%
2 Mar 2015